Novel therapeutics development highlighted in Australasian Biotechnology journal


Australia’s life science strengths and success stories are highlighted in the latest edition of Australasian Biotechnology, AusBiotech’s official journal, in anticipation of the upcoming AusBiotech 2023 and AusBioInvest 2023 conferences.

The sector’s recent successes have significantly progressed Australia’s biotechnology industry, strengthening Australia’s position in the global biotech ecosystem.

This journal edition offers local insights into global issues and trends impacting the sector and provides homegrown approaches to tackling challenges such as talent attraction and workforce retention, 3Rs alternatives, and patent protection for artificial intelligence-developed therapies. These topics will be expanded upon at the AusBiotech 2023 national conference in Brisbane.

Providing a platform for education, the journal strengthens and grows industry knowledge of Australian capabilities and enablers through commentary from a diverse range of authors. This edition’s themes include medicines development, manufacturing, and taking Australia globally.

Read compelling insights from sector leaders, including Navigating the future: predictions and potentials of Australian biotechnology by Emeritus Professor Ian Frazer AC FRS, Frazer Institute, The University of Queensland, Introducing Australia’s powerhouse for innovative biotech ventures, by Dr Andrew Nash, CSL; Professor Alan Cowman AC, WEHI; and Professor Mark Hargreaves AM, The University of Melbourne, and Creating an industry – small biotech and the RNA revolution, by Dr Gisela Mautner, CEO and Managing Director, Noxopharm.

The journal also reflects on AusMedtech 2023, the biggest AusMedtech to date, and the AusMedtech 2023 Early-Stage Innovation Forum, which showcased emerging medtech innovations and experts developing breakthrough solutions for patients.

This edition also contains regular features, including the AusBiotech CEO Report, and AusBioStock – an exclusive report from David Nayagam, Evans & Partners. The journal welcomes new AusBiotech members, and holds a list of AusBiotech corporate members.

In-depth commentary on the Australian and global biotechnology sector will continue at AusBiotech 2023, from 1-3 November in Brisbane, and AusBioInvest 2023 on 30 October in Melbourne. AusBiotech thanks the support of Host State Partners, Queensland Government and Victoria State Government (respectively).

The next edition of Australasian Biotechnology will be released in April 2024 and will feature Australian and international medtech success stories.

Contact if you are interested in contributing or to find out about advertising opportunities. 

Australasian Biotechnology is published bi-annually in partnership with Executive Media. Download the Australasian Biotechnology journal today.